Ltc4 is a lipid of Fatty Acyls (FA) class. Ltc4 is associated with abnormalities such as Asthma, Eosinophilia, Pulmonary Eosinophilia, Pneumonia and Cardiovascular Diseases. The involved functions are known as Signal, Gene Expression, Stimulus, Signal Transduction and Metabolic Inhibition. Ltc4 often locates in Plasma membrane, Cytoplasm, Back, Cytoplasmic and Tissue membrane. The associated genes with LTC4 are STIM1 gene, ABCC2 gene, CD9 gene, Mutant Proteins and Amino Acids, Aromatic. The related lipids are glycolithocholate.
To understand associated biological information of LTC4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
LTC4 is suspected in Pneumonia, Asthma, Pulmonary Eosinophilia, Eosinophilia, Cardiovascular Diseases, Disintegration and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with LTC4
Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTC4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Matsushita N et al. | Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects. | 1998 | Jpn. J. Pharmacol. | pmid:9804057 |
Cunningham FM et al. | Pharmacology of the 5-lipoxygenase inhibitors BAY Y 1015 and BAY X 1005 in the horse. | 1997 | J. Vet. Pharmacol. Ther. | pmid:9280370 |
Shichinohe K et al. | Effect of M-711 on experimental skin reactions induced by chemical mediators in rats. | 1996 | J. Vet. Med. Sci. | pmid:8741601 |
Bouchelouche K et al. | The cysteinyl-leukotriene D4 induces cytosolic Ca2+ elevation and contraction of the human detrusor muscle. | 2003 | J. Urol. | pmid:12853847 |
O'Neil GS et al. | Effect of surgical preparation and arterialization on vasomotion of human saphenous vein. | 1994 | J. Thorac. Cardiovasc. Surg. | pmid:8127099 |
Utoh J et al. | Is an increase in neutrophil leukotriene-generating capacity a specific phenomenon for cardiopulmonary bypass? | 1995 | J. Thorac. Cardiovasc. Surg. | pmid:7609558 |
Hong F and Yang S | Ischemic preconditioning decreased leukotriene C4 formation by depressing leukotriene C4 synthase expression and activity during hepatic I/R injury in rats. | 2012 | J. Surg. Res. | pmid:22921920 |
Yang SL et al. | Increased leukotriene c4 synthesis accompanied enhanced leukotriene c4 synthase expression and activities of ischemia-reperfusion-injured liver in rats. | 2007 | J. Surg. Res. | pmid:17397868 |
Bacha EA et al. | Gastric antigen challenge releases gastrin and eicosanoids and protects against ethanol. | 1997 | J. Surg. Res. | pmid:9228931 |
Foller M et al. | Participation of leukotriene C(4) in the regulation of suicidal erythrocyte death. | 2009 | J. Physiol. Pharmacol. | pmid:19826192 |
Lukaszyk A et al. | The role of epidermal growth factor in platelet-endothelium interactions. | 1998 | J. Physiol. Pharmacol. | pmid:9670106 |
Suzuki Y and Ra C | Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: aspirin modulation of IgE-dependent mast cell activation: role of aspirin-induced exacerbation of immediate allergy. | 2009 | J. Pharmacol. Sci. | pmid:19609060 |
Kusuhara H et al. | Characterization of efflux transport of organic anions in a mouse brain capillary endothelial cell line. | 1998 | J. Pharmacol. Exp. Ther. | pmid:9618431 |
Munoz NM et al. | Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4. | 1994 | J. Pharmacol. Exp. Ther. | pmid:8301549 |
Sathirakul K et al. | Multiple transport systems for organic anions across the bile canalicular membrane. | 1994 | J. Pharmacol. Exp. Ther. | pmid:8301595 |
Pedersen KE et al. | Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism. | 1997 | J. Pharmacol. Exp. Ther. | pmid:9152370 |
Gissurarson SR et al. | Effect of lobaric acid on cysteinyl-leukotriene formation and contractile activity of guinea pig taenia coli. | 1997 | J. Pharmacol. Exp. Ther. | pmid:9023290 |
Hundley TR et al. | Characteristics of arachidonic acid generation in human basophils: relationship between the effects of inhibitors of secretory phospholipase A2 activity and leukotriene C4 release. | 1998 | J. Pharmacol. Exp. Ther. | pmid:9495842 |
McAlexander MA et al. | Inhibition of 5-lipoxygenase diminishes neurally evoked tachykinergic contraction of guinea pig isolated airway. | 1998 | J. Pharmacol. Exp. Ther. | pmid:9580604 |
Brochu-Bourque A et al. | Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor. | 2011 | J. Pharmacol. Exp. Ther. | pmid:20966037 |
Tominaga M et al. | ONO-1078 antagonizes diarrhea-causing changes in ion transport and smooth muscle contraction induced by peptidoleukotrienes in rat and human colon in vitro. | 1996 | J. Pharmacol. Exp. Ther. | pmid:8819486 |
Ezeamuzie CI et al. | Antiallergic and antiasthmatic effects of a novel enhydrazinone ester (CEE-1): inhibition of activation of both mast cells and eosinophils. | 2014 | J. Pharmacol. Exp. Ther. | pmid:24917545 |
Aoki M et al. | Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor. | 2001 | J. Pharmacol. Exp. Ther. | pmid:11504812 |
Zhang XC et al. | Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17483291 |
Masereeuw R et al. | Active lucifer yellow secretion in renal proximal tubule: evidence for organic anion transport system crossover. | 1999 | J. Pharmacol. Exp. Ther. | pmid:10215693 |
Dantzig AH et al. | Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities. | 1999 | J. Pharmacol. Exp. Ther. | pmid:10411602 |
Casolaro V et al. | Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. | 1993 | J. Pharmacol. Exp. Ther. | pmid:7505332 |
Loe DW et al. | Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). | 2000 | J. Pharmacol. Exp. Ther. | pmid:10773025 |
Prié S et al. | Leukotriene C4 receptors on guinea pig tracheocytes. | 1995 | J. Pharmacol. Exp. Ther. | pmid:7562565 |
Malaviya R et al. | Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97). | 2000 | J. Pharmacol. Exp. Ther. | pmid:11082424 |
Capper EA et al. | Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis. | 2000 | J. Pharmacol. Exp. Ther. | pmid:11082441 |
Rius M et al. | ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4). | 2008 | J. Pharmacol. Exp. Ther. | pmid:17959747 |
Rao NL et al. | Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17371808 |
Abad MJ et al. | Effects of furocoumarins from Cachrys trifida on some macrophage functions. | 2001 | J. Pharm. Pharmacol. | pmid:11518028 |
Fernández MA et al. | New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. | 2001 | J. Pharm. Pharmacol. | pmid:11732756 |
Ebersole JL et al. | Inflammatory mediators and immunoglobulins in GCF from healthy, gingivitis and periodontitis sites. | 1993 | J. Periodont. Res. | pmid:8263728 |
Cruz JR et al. | Fecal excretion of leukotriene C4 during human disease due to Shigella dysenteriae. | 1995 | J. Pediatr. Gastroenterol. Nutr. | pmid:7714683 |
Shimizu T et al. | Leukotriene B4 and C4 metabolism in small intestine mucosa of children with celiac disease. | 1995 | J. Pediatr. Gastroenterol. Nutr. | pmid:8583294 |
Cao D et al. | Chronic administration of ethyl docosahexaenoate reduces gerbil brain eicosanoid productions following ischemia and reperfusion. | 2006 | J. Nutr. Biochem. | pmid:16098734 |
Dhillon HS et al. | Regional generation of leukotriene C4 after experimental brain injury in anesthetized rats. | 1996 | J. Neurotrauma | pmid:9002063 |
Farias S et al. | Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury. | 2009 | J. Neurotrauma | pmid:19886806 |
Paoletti P et al. | CSF leukotriene C4 following subarachnoid hemorrhage. | 1988 | J. Neurosurg. | pmid:3418380 |
Black KL et al. | Enzymatic barrier protects brain capillaries from leukotriene C4. | 1994 | J. Neurosurg. | pmid:7931622 |
Rao AM et al. | CDP-choline: neuroprotection in transient forebrain ischemia of gerbils. | 1999 | J. Neurosci. Res. | pmid:10561698 |
Hashizume K and Black KL | Increased endothelial vesicular transport correlates with increased blood-tumor barrier permeability induced by bradykinin and leukotriene C4. | 2002 | J. Neuropathol. Exp. Neurol. | pmid:12152787 |
Black P et al. | Chemotherapy in experimental brain tumor, part 2: pretreatment with leukotriene C4 prolongs survival. | 1998 | J. Neurooncol. | pmid:9525821 |
Constable AL et al. | DMSO induction of the leukotriene LTC4 by Lewis rat Schwann cells. | 1999 | J. Neurol. Sci. | pmid:10202977 |
Farias SE et al. | Transcellular biosynthesis of cysteinyl leukotrienes in rat neuronal and glial cells. | 2007 | J. Neurochem. | pmid:17711426 |
Fujii R et al. | Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. | 1994 | J. Natl. Cancer Inst. | pmid:7966417 |
Xiang Y et al. | Anti-inflammatory effect of acetylpuerarin on eicosanoid signaling pathway in primary rat astrocytes. | 2014 | J. Mol. Neurosci. | pmid:24026619 |